Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2002 1
2003 1
2004 3
2005 2
2006 5
2007 4
2008 2
2009 6
2010 10
2011 8
2012 10
2013 15
2014 16
2015 12
2016 11
2017 14
2018 9
2019 8
2020 6
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 25593202

120 results
Results by year
Filters applied: . Clear all
Page 1
Diffusion and perfusion MRI to differentiate treatment-related changes including pseudoprogression from recurrent tumors in high-grade gliomas with histopathologic evidence.
Prager AJ, Martinez N, Beal K, Omuro A, Zhang Z, Young RJ. Prager AJ, et al. AJNR Am J Neuroradiol. 2015 May;36(5):877-85. doi: 10.3174/ajnr.A4218. Epub 2015 Jan 15. AJNR Am J Neuroradiol. 2015. PMID: 25593202 Free PMC article.
Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma.
Thomas AA, Arevalo-Perez J, Kaley T, Lyo J, Peck KK, Shi W, Zhang Z, Young RJ. Thomas AA, et al. J Neurooncol. 2015 Oct;125(1):183-90. doi: 10.1007/s11060-015-1893-z. Epub 2015 Aug 15. J Neurooncol. 2015. PMID: 26275367 Free PMC article.
Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade Glioma.
Boxerman JL, Ellingson BM, Jeyapalan S, Elinzano H, Harris RJ, Rogg JM, Pope WB, Safran H. Boxerman JL, et al. Am J Clin Oncol. 2017 Jun;40(3):228-234. doi: 10.1097/COC.0000000000000156. Am J Clin Oncol. 2017. PMID: 25436828
Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements.
Hu LS, Baxter LC, Smith KA, Feuerstein BG, Karis JP, Eschbacher JM, Coons SW, Nakaji P, Yeh RF, Debbins J, Heiserman JE. Hu LS, et al. AJNR Am J Neuroradiol. 2009 Mar;30(3):552-8. doi: 10.3174/ajnr.A1377. Epub 2008 Dec 4. AJNR Am J Neuroradiol. 2009. PMID: 19056837 Free PMC article. Clinical Trial.
Differentiation between brain tumor recurrence and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy.
Bobek-Billewicz B, Stasik-Pres G, Majchrzak H, Zarudzki L. Bobek-Billewicz B, et al. Folia Neuropathol. 2010;48(2):81-92. Folia Neuropathol. 2010. PMID: 20602289 Free article.
Diffusion-weighted MR imaging for the differentiation of true progression from pseudoprogression following concomitant radiotherapy with temozolomide in patients with newly diagnosed high-grade gliomas.
Lee WJ, Choi SH, Park CK, Yi KS, Kim TM, Lee SH, Kim JH, Sohn CH, Park SH, Kim IH. Lee WJ, et al. Acad Radiol. 2012 Nov;19(11):1353-61. doi: 10.1016/j.acra.2012.06.011. Epub 2012 Aug 11. Acad Radiol. 2012. PMID: 22884399 Clinical Trial.
Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging.
Choi YJ, Kim HS, Jahng GH, Kim SJ, Suh DC. Choi YJ, et al. Acta Radiol. 2013 May;54(4):448-54. doi: 10.1177/0284185112474916. Epub 2013 Apr 30. Acta Radiol. 2013. PMID: 23592805
Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.
Xu Q, Liu Q, Ge H, Ge X, Wu J, Qu J, Xu K. Xu Q, et al. Medicine (Baltimore). 2017 Dec;96(50):e9332. doi: 10.1097/MD.0000000000009332. Medicine (Baltimore). 2017. PMID: 29390403 Free PMC article.
Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging.
Arvinda HR, Kesavadas C, Sarma PS, Thomas B, Radhakrishnan VV, Gupta AK, Kapilamoorthy TR, Nair S. Arvinda HR, et al. J Neurooncol. 2009 Aug;94(1):87-96. doi: 10.1007/s11060-009-9807-6. Epub 2009 Feb 20. J Neurooncol. 2009. PMID: 19229590 Retracted.
Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
Seeger A, Braun C, Skardelly M, Paulsen F, Schittenhelm J, Ernemann U, Bisdas S. Seeger A, et al. Acad Radiol. 2013 Dec;20(12):1557-65. doi: 10.1016/j.acra.2013.09.003. Acad Radiol. 2013. PMID: 24200483
120 results
Jump to page
Feedback